Patents by Inventor Hamid MOHA OU MAATI

Hamid MOHA OU MAATI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Retro-inverso analogs of spadin display increased antidepressant effects
    Patent number: 10251937
    Abstract: Compositions, pharmaceutical compositions and biodegradable pharmaceutical compositions containing at least one analog of spadin or at least one analog of a propeptides of spadin or mixtures thereof are described. Methods for treating depression using the analogs of spadin or analogs of propeptides of spadin or mixtures thereof, as well as methods for blocking TREK-1 channel activity are also disclosed.
    Type: Grant
    Filed: January 27, 2015
    Date of Patent: April 9, 2019
    Assignees: MEDINCELL, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Georges Gaudriault, Catherine Heurteaux, Jean Mazella, Marc Borsotto, Hamid Moha Ou Maati, Julie Veyssiere
  • RETRO-INVERSO ANALOGS OF SPADIN DISPLAY INCREASED ANTIDEPRESSANT EFFECTS
    Publication number: 20170072013
    Abstract: Compositions, pharmaceutical compositions and biodegradable pharmaceutical compositions containing at least one analog of spadin or at least one analog of a propeptides of spadin or mixtures thereof are described. Methods for treating depression using the analogs of spadin or analogs of propeptides of spadin or mixtures thereof, as well as methods for blocking TREK-1 channel activity are also disclosed.
    Type: Application
    Filed: January 27, 2015
    Publication date: March 16, 2017
    Applicants: MEDINCELL, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Georges GAUDRIAULT, Catherine HEURTEAUX, Jean MAZELLA, Marc BORSOTTO, Hamid MOHA OU MAATI, Julie VEYSSIERE
  • NOVEL USES FOR TRADITIONAL CHINESE MEDICINE
    Publication number: 20130287870
    Abstract: The present invention relates to the use of one or more Neuroaid2 components to activate KATP channels and in the treatment of various diseases and disorders. The one or more Neuroaid2 components are selected from the group consisting of: Salviae Miltiorrhizae, Prunus persica; Polygalae; acori tatarinowii; Astragali; Paeoniae Rubra; Chuanxiong; Carthamus tinctorius; and angelicae sinensis.
    Type: Application
    Filed: March 25, 2013
    Publication date: October 31, 2013
    Inventors: Hamid MOHA OU MAATI, Michel LAZDUNSKI, Catherine HEURTEAUX, David PICARD